SCHEMBL6483822

SCHEMBL6483822

NC(=O)c1cnn(-c2ncc(Cl)cc2Cl)c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.49
RAB9A P51151 3/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TSHR P16473 1/20 0.45
NPC1 O15118 1/20 0.42
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.38
FGFR1 P11362 4/20 0.38
SRC P12931 4/20 0.38
FGFR2 P21802 4/20 0.38
FGFR4 P22455 4/20 0.38
FGFR3 P22607 4/20 0.38
KDR P35968 4/20 0.38
PLAU P00749 1/20 0.36
NNMT P40261 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
TYK2 P29597 2/20 0.35
MALT1 Q9UDY8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10690689 0.89 PTPN1 (0.43) RIPK2RAB9ALMNASMN1; SMN2TSHR
SCHEMBL6476731 0.84 MAPK1 (0.56) RIPK2RAB9ALMNASMN1; SMN2TSHR
SCHEMBL6476695 0.83 MAPT (0.51) RIPK2RAB9ALMNASMN1; SMN2NPC1
SCHEMBL10687209 0.81 HTT (0.63) RAB9ASMN1; SMN2TSHRNPC1HTT
SCHEMBL3610078 0.79 RIPK2 (0.55) RIPK2RAB9ALMNASMN1; SMN2TSHR
SCHEMBL6475335 0.77 RIPK2 (0.52) RIPK2RAB9ALMNASMN1; SMN2TSHR
SCHEMBL10717398 0.77 LMNA (0.36) RAB9ALMNANPC1MAPK1HTT
SCHEMBL27681336 0.77 ALKBH1 (0.43) LMNASMN1; SMN2TSHRMAPK1MALT1
SCHEMBL1691724 0.75 RIPK2 (0.60) RIPK2RAB9ALMNASMN1; SMN2TSHR
SCHEMBL15741922 0.74 MALT1 (0.37) LMNASMN1; SMN2HTTSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209251-A1 Substituted pyrazolo-pyrimidine-4-ones BAYER CROPSCIENCE AG (DE) 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209251-A1 Substituted pyrazolo-pyrimidine-4-ones P2RX4, DHFR, DDT RIPK2 3879/4885RAB9A 1742/4885LMNA 3953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.